Community

Puerto Rican Scientist Leads Development of Skin Cancer Vaccine

Published Sep 28, 2026, 10:40 PM ASTvia Primera Hora

At a glance

  • Dr. Deborah Soto-Ortega is leading the development of a skin cancer vaccine at Moderna
  • The vaccine is currently in phase 3 clinical trials
  • The recent announcement from Moderna indicates positive results from the phase 3 data

Why this matters: For Puerto Rico, Dr. Soto-Ortega’s leadership in the development of a skin cancer vaccine highlights the island’s contribution to groundbreaking medical research and innovation.

Dr. Deborah Soto-Ortega, a scientist from Aguada, Puerto Rico, is leading the development of a skin cancer vaccine at Moderna’s facility in Marlborough, Massachusetts. Soto-Ortega studied biotechnology at the University of Puerto Rico and later earned a doctorate in biomedical engineering from the University of South Carolina. She worked at Amgen in Puerto Rico before joining Moderna in 2022 to lead the phase 3 study of the skin cancer program.

As site head, Soto-Ortega oversees the team responsible for developing the vaccine, which is currently in clinical trials. The recent announcement from Moderna indicates that the phase 3 data for the skin cancer vaccine has shown positive results, bringing new hope for the treatment of one of the most impactful cancers worldwide.

SourcePrimera Hora

More in Community